Marco Bortolato Selected Research

SK&F 82958 (SKF 82958)

1/2021	The α6 GABAA Receptor Positive Allosteric Modulator DK-I-56-1 Reduces Tic-Related Behaviors in Mouse Models of Tourette Syndrome.
1/2017	The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marco Bortolato Research Topics

Disease

12	Schizophrenia (Dementia Praecox) 01/2017 - 02/2007
10	Psychotic Disorders (Schizoaffective Disorder) 10/2017 - 01/2004
9	Parkinson Disease (Parkinson's Disease) 01/2022 - 10/2008
6	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 01/2022 - 01/2011
6	Tics (Tic) 01/2022 - 12/2014
6	Tourette Syndrome (Tourette's Syndrome) 12/2016 - 12/2007
5	Antisocial Personality Disorder (Antisocial Personality) 02/2022 - 01/2011
5	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2021 - 07/2010
4	Alopecia (Baldness) 01/2021 - 01/2011
3	Gambling (Pathological Gambling) 01/2022 - 06/2012
3	Sleep Deprivation 01/2020 - 11/2008
3	Epilepsy (Aura) 09/2014 - 05/2007
2	Conduct Disorder (Conduct Disorders) 01/2022 - 11/2020
2	Restless Legs Syndrome (Restless Legs) 01/2022 - 01/2017
2	Substance-Related Disorders (Drug Abuse) 01/2019 - 12/2008
2	Dyskinesias (Dyskinesia) 01/2019 - 01/2017
2	Autism Spectrum Disorder 11/2018 - 05/2013
2	Autistic Disorder (Autism) 11/2018 - 01/2011
2	Cognitive Dysfunction 10/2018 - 01/2005
2	Bipolar Disorder (Manic Depressive Psychosis) 01/2017 - 02/2007
2	Mental Disorders (Mental Disorder) 01/2011 - 10/2008
2	Absence Epilepsy (Childhood Absence Epilepsy) 05/2010 - 07/2007
1	Postpartum Depression (Post-Natal Depression) 01/2022
1	Seizures (Absence Seizure) 01/2022
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2022
1	Neuralgia (Stump Neuralgia) 01/2021
1	Opioid-Related Disorders (Opiate Addiction) 01/2021
1	Hyperalgesia 01/2021
1	Pain (Aches) 01/2021
1	Catalepsy 01/2021
1	Bradycardia 11/2019
1	Wounds and Injuries (Trauma) 01/2019
1	Hypoglycemia (Reactive Hypoglycemia) 10/2018
1	Mania (Manias) 10/2017
1	Paraphilic Disorders (Paraphilia) 04/2015
1	Marijuana Abuse (Cannabis Abuse) 06/2014
1	Paranoid Disorders (Paranoia) 07/2013
1	Binge Drinking 08/2012
1	Alcoholism (Alcohol Abuse) 08/2012
1	Anxiety Disorders (Anxiety Disorder) 04/2012
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2011
1	Prostatic Neoplasms (Prostate Cancer) 01/2011
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2011
1	Benign essential blepharospasm 07/2010
1	Mood Disorders (Mood Disorder) 10/2008
1	Body Weight (Weight, Body) 11/2007

Drug/Important Bio-Agent (IBA)

13	Finasteride (Propecia)FDA LinkGeneric 01/2022 - 12/2007
6	Monoamine Oxidase (MAO)IBA 11/2020 - 10/2008
6	NeurosteroidsIBA 01/2020 - 12/2008
6	Dopamine (Intropin)FDA LinkGeneric 01/2019 - 06/2008
5	Antipsychotic Agents (Antipsychotics)IBA 12/2014 - 06/2005
4	Pramipexole (Mirapex)FDA LinkGeneric 01/2022 - 01/2017
4	Pharmaceutical PreparationsIBA 01/2021 - 07/2013
4	SteroidsIBA 01/2021 - 01/2011
4	Dopamine Agonists (Dopamine Agonist)IBA 01/2020 - 01/2017
4	CannabinoidsIBA 06/2014 - 01/2005
3	Serotonin (5 Hydroxytryptamine)IBA 01/2022 - 06/2008
3	Dutasteride (Avodart)FDA Link 01/2019 - 01/2011
3	EnzymesIBA 01/2019 - 01/2017
3	GABA-B ReceptorsIBA 05/2010 - 01/2004
2	Dopamine Receptors (Dopamine Receptor)IBA 01/2022 - 01/2016
2	Pregnanolone (Allopregnanolone)IBA 01/2022 - 01/2017
2	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 01/2022 - 11/2019
2	SK&F 82958 (SKF 82958)IBA 01/2021 - 01/2017
2	ropinirole (Requip)FDA LinkGeneric 01/2020 - 01/2017
2	Levodopa (L Dopa)FDA LinkGeneric 01/2019 - 01/2017
2	Butyric Acid (Butanoic Acid)IBA 05/2010 - 10/2007
2	EndocannabinoidsIBA 12/2008 - 10/2007
1	N-Methylaspartate (NMDA)IBA 02/2022
1	Antidepressive Agents (Antidepressants)IBA 01/2022
1	Dopamine AntagonistsIBA 01/2021
1	Opioid Analgesics (Opioids)IBA 01/2021
1	Dopamine D1 Receptors (Dopamine D1 Receptor)IBA 01/2021
1	KetanserinIBA 11/2019
1	volinanserinIBA 11/2019
1	Biological ProductsIBA 01/2019
1	CalciumIBA 10/2018
1	Insulin (Novolin)FDA Link 10/2018
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 10/2018
1	Verapamil (Calan)FDA LinkGeneric 10/2018
1	Haloperidol (Haldol)FDA LinkGeneric 01/2017
1	Methionine (L-Methionine)FDA Link 01/2017
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 01/2017
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2017
1	5-alpha Reductase InhibitorsIBA 01/2017
1	Valine (L-Valine)FDA Link 01/2017
1	Oxidopamine (6 Hydroxydopamine)IBA 01/2017
1	Nonsense Codon (Nonsense Mutation)IBA 01/2016
1	CorticosteroneIBA 01/2016
1	AndrogensIBA 10/2012
1	Ethanol (Ethyl Alcohol)IBA 08/2012
1	Therapeutic UsesIBA 01/2011
1	IsoenzymesIBA 01/2011
1	Botulinum Toxins (Botulinum Toxin)IBA 07/2010
1	Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA 10/2008
1	Sucrose (Saccharose)IBA 11/2007
1	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 11/2007

Therapy/Procedure

9	Therapeutics 01/2022 - 01/2004
2	Self Administration (Administration, Self) 01/2021 - 08/2012
2	Vagus Nerve Stimulation 09/2014 - 03/2013